jw pharmaceutical (001060:Korea SE)
jw pharmaceutical (001060) Snapshot
|
Open
18,700
|
Previous Close
18,400
|
|
|
Day High
18,800
|
Day Low
17,850
|
|
|
52 Week High
05/3/13 - 20,950
|
52 Week Low
07/26/12 - 11,048
|
|
|
Market Cap
234.0B
|
Average Volume 10 Days
166.7K
|
|
|
EPS TTM
-1,881.00
|
Shares Outstanding
12.8M
|
|
|
EX-Date
12/27/12
|
P/E TM
--
|
|
|
Dividend
125.00
|
Dividend Yield
0.68%
|
Related News
jw pharmaceutical (001060) Related Businessweek News
No Related Businessweek News Foundjw pharmaceutical (001060) Details
JW Pharmaceutical engages in the production and sale of pharmaceutical products primarily in South Korea. Its products comprise diabetic agents, urology agents, CNS products, nephrology agents, analgesics, antipyretics, cold remedy products, antidote agents, antimicrobials, anticancer agents, antifungal agents, cardiovascular agents, gastrointestinal agents, multivitamins and antianemic agents, contact lens care and ophthalmic agents, topicals, nephrology agents, amino acid solutions, flexible I.V. containers, I.V. solutions, respiratory agents, and OBGY agents. The company also licenses its chemical entities technologies for the treatment of breast cancer and irritable bowel syndrome, as well as offers active pharmaceutical ingredients and bulk pharmaceutical products. It also exports its products to European union and Japan. The company was formerly known as Choongwae Pharma Corporation and changed its name to JW Pharmaceutical on April 21, 2011. JW Pharmaceutical was founded in 1945 and is based in Seoul, South Korea.
jw pharmaceutical (001060) Key Developments
JW Pharmaceutical Corporation, Annual General Meeting, Mar 15, 2013., at 09:00 Korea Standard Time. Location: dong, Seocho-gu. Agenda: To consider audit report and sales reporting; to consider the financial statement; to consider the appointment of director; and to consider the directors remuneration limit.
JW Pharmaceutical, Annual General Meeting, Mar 23, 2012.
JW Pharmaceutical will be removed from the KOSPI 200 Index, effective June 10, 2011.
| Recently Viewed | |||
| 001060:KS | 18,300.00 KRW | -100.00 | |
| Company | Last | Change | |
| No competitor information is available for 001060. | |||
| View Industry Companies | |||
Industry Analysis
001060
Industry Average
| Valuation | 001060 | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.5x |
|
| Price/Book | 1.1x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.0x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact JW PHARMACEUTICAL, please visit www.cwp.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.







